z-logo
open-access-imgOpen Access
Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD)
Author(s) -
Pouw J. N.,
Leijten E. F. A.,
Laar J. M.,
Boes M.
Publication year - 2021
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13542
Subject(s) - autoantibody , immunology , medicine , antibody , disease , pathogenesis , rheumatoid factor , autoimmune disease , autoimmunity , pathology
Autoimmune rheumatic diseases (AIRD) are categorized as seropositive or seronegative, based on the presence or absence of a defined set of autoantibodies. Autoantibodies in AIRD are produced after loss of B cell tolerance, as a consequence of defects incurred during early B cell development, genetic variants in products regulating B and T cell peripheral tolerance, environmental factors, or immunologic triggers. Emerging evidence now suggests that AIRD that were previously considered seronegative do have autoreactive B cells and autoantibodies that contribute to disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom